Cargando…
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry
This review, written from the perspective of the plasma industry, discusses plasma procurement and plasma product safety in light of the COVID‐19 pandemic. The COVID‐19 pandemic impacted the whole world and, therefore, not unexpectedly, the pharmaceutical industry too. In spite of this, the plasma p...
Autores principales: | Turecek, Peter L., Hibbett, Deborah, Kreil, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115499/ https://www.ncbi.nlm.nih.gov/pubmed/35298841 http://dx.doi.org/10.1111/vox.13267 |
Ejemplares similares
-
Orthopox viruses and the safety margins of solvent‐detergent treated plasma‐derived medicinal products
por: Kindermann, Johanna, et al.
Publicado: (2022) -
West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States
por: Planitzer, Christina B., et al.
Publicado: (2009) -
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
por: Roth, Nathan J., et al.
Publicado: (2020) -
Biochemical and cellular markers differentiate recovered, in‐line filtered plasma, and plasma obtained by apheresis methods
por: Siekmann, Jürgen, et al.
Publicado: (2021) -
Perspectives for immune plasma treatment of COVID-19
por: SAYINALP, Başak, et al.
Publicado: (2021)